A Study of mRNA-3745 in Adult and Pediatric Participants With Glycogen Storage Disease Type 1a (GSD1a)

Running, not enrolling · Phase 1/Phase 2

Conditions studied: Glycogen Storage Disease

In brief

The main goal of this trial is to evaluate the safety and tolerability of mRNA-3745 via intravenous (IV) administration in adult and pediatric participants with GSD1a.

Key facts

Study ID
NCT05095727
Run by
ModernaTX, Inc.
People needed
15
Starts
2022-06-01
Expected to finish
2026-11-30
Last updated by the study team
2025-12-15

Who can join

Age: 6 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.